Products for Research Use Only
RegisterLogin

ROC-325

CAT: 0804-HY-103706-01Size: 5 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-103706-01Size:5 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
ROC-325 is a potent and orally active autophagy inhibitor with a strong anticancer activity. ROC-325 induces the deacidification of lysosomes, accumulation of autophagosomes, and disrupted autophagic flux. ROC-325 also induces renal cell carcinoma apoptosis[1].
CAS Number
1859141-26-6
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Apoptosis; Autophagy
Type
Reference compound
Related Pathways
Apoptosis; Autophagy
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/ROC-325.html
Purity
99.45
Solubility
DMSO : 4.55 mg/mL (ultrasonic; warming) |H2O : < 0.1 mg/mL
Smiles
O=C1C2=C(SC3=C1C=CC=C3)C(C)=CC=C2NCCN(CCNC4=CC=NC5=CC(Cl)=CC=C45)C
Molecular Formula
C28H27ClN4OS
Molecular Weight
503.06
Precautions
H302, H315, H319, H335
References & Citations
[1]Carew JS, et al. Disruption of Autophagic Degradation with ROC-325 Antagonizes Renal Cell Carcinoma Pathogenesis. Clin Cancer Res. 2017 Jun 1;23 (11) :2869-2879.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Related Products

CatalogName
HY-145384-01ROC-0929
HY-P991634IBI-325
HY-P990312-01ABT-325
HY-119229-01VRT-325
HY-179211CliMB-325
HY-W952727CRBN ligand-325
HY-R00683-01Hsa-miR-325 mimic
HY-R00683A-01Hsa-miR-325 agomir
HY-P10109-01G6PI 325-339 (human)
HY-P5502Influenza NP (311-325)

Alternative Products

CatalogName
464799-01ROC 325
T16777-01ROC-325
A17031-50ROC-325 50mg
A17031-2ROC-325 2mg
A17031-100ROC-325 100mg
A17031-25ROC-325 25mg
A17031-5ROC-325 5mg
A17031-1ROC-325 1mg

Popular Products